1. Comparison of Cardiovascular Events in Elderly and Younger Crohn's Disease Patients Treated With Certolizumab Pegol: Results From a Pooled Safety Analysis: 1832. (October 2015) Authors: Ha, Christina; Choi, Jennifer; Katz, Seymour; Kosutic, Gordana; Spearman, Marshall; Coarse, Jason; Hasan, Iram; Loftus, Edward V. Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Covariates Influencing the Exposure‐Response Relationship for Certolizumab Pegol During the Induction and Maintenances Phases in Patients with Crohn's Disease: 572. (October 2016) Authors: Casteele, Niels Vande; Feagan, Brian; Vermeire, Séverine; Yassine, Mohamed; Hasan, Iram; Coarse, Jason; Kosutic, Gordana; Sandborn, William J. Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Incidence of Benign and Malignant Neoplasms in Crohn's Disease Patients Aged ≤30 Years Versus 30‐64 Years Treated With Certolizumab Pegol: Results From a Pooled Safety Analysis of 15 Studies: 1831. (October 2015) Authors: Choi, Jennifer; Ha, Christina; Kosutic, Gordana; Spearman, Marshall; Coarse, Jason; Hasan, Iram; Loftus, Edward V. Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long‐Term Safety and Efficacy of Certolizumab Pegol Therapy in Patients With Moderate to Severe Crohn's Disease: 5‐Year Results: 1821. (October 2015) Authors: Ptak, Theadore; Younes, Ziad; Shafran, Ira; Lee, Scott; Miner, Philip B.; Kayhan, Cem; Kosutic, Gordana; Coarse, Jason; Hasan, Iram; Spearman, Marshall; Sandborn, William J. Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P-098 Serious Infections in Patients Treated with Certolizumab Pegol with or Without Corticosteroids: Pooled Safety Data from 15 Clinical Trials. (March 2016) Authors: Abraham, Bincy; Wolf, Doug; Regueiro, Miguel; Randall, Charles; Kosutic, Gordana; Spearman, Marshall; Coarse, Jason; Hasan, Iram; Loftus, Edward Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P-098 Serious Infections in Patients Treated with Certolizumab Pegol with or Without Corticosteroids: Pooled Safety Data from 15 Clinical Trials. (March 2016) Authors: Abraham, Bincy; Wolf, Doug; Regueiro, Miguel; Randall, Charles; Kosutic, Gordana; Spearman, Marshall; Coarse, Jason; Hasan, Iram; Loftus, Edward Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P-099 Sex-Based Differences in Adverse Events of Crohn's Disease Patients Treated with Certolizumab Pegol: A Pooled Safety Analysis of 15 Studies. (March 2016) Authors: Kane, Sunanda; Loftus, Edward; Choudhary, Cuckoo; Randall, Charles; Ali, Tauseef; Kosutic, Gordana; Hasan, Iram; Coarse, Jason; Spearman, Marshall; Regueiro, Miguel Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-099 Sex-Based Differences in Adverse Events of Crohn's Disease Patients Treated with Certolizumab Pegol: A Pooled Safety Analysis of 15 Studies. (March 2016) Authors: Kane, Sunanda; Loftus, Edward; Choudhary, Cuckoo; Randall, Charles; Ali, Tauseef; Kosutic, Gordana; Hasan, Iram; Coarse, Jason; Spearman, Marshall; Regueiro, Miguel Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-100 Improvement in Quality of Life as a Predictor of Long-Term Remission in Crohn's Disease Patients Treated with Certolizumab Pegol. (March 2016) Authors: Feagan, Brian; Schreiber, Stefan; Spearman, Marshall; Kosutic, Gordana; Hasan, Iram; Coarse, Jason; Sandborn, William Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P-100 Improvement in Quality of Life as a Predictor of Long-Term Remission in Crohn's Disease Patients Treated with Certolizumab Pegol. (March 2016) Authors: Feagan, Brian; Schreiber, Stefan; Spearman, Marshall; Kosutic, Gordana; Hasan, Iram; Coarse, Jason; Sandborn, William Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗